AMETEK INC/ AME
AMETEK INC/ is an industrial instruments for measurement, display, and control issuer listed as AME on NYSE. This free Atlas page links SEC CIK 1037868, Nasdaq Trader and TradingView NYSE:AME, related symbols and the workstation route before a full report is run.
AME public profile
Industrial instruments for measurement, display, and control issuer. Atlas tracks AME through its NYSE listing record, chart route and source links.
AME trades on NYSE. SEC CIK 1037868. Chart route NYSE:AME.
Nasdaq Trader is the listing identity source for AMETEK INC/. Atlas files AME under USA Stocks for browsing. The canonical public URL is /stocks/AME/. The workstation link below opens the fuller research run.
Market Wit preview
AMETEK's latest evidence has the useful awkwardness of a real industrial business: a company can report $1.93B of revenue, $514.9M of operating income and $399.4M of net income for the quarter ended 2026-03-31, then still remind everyone that the machinery of profit is built from suppliers, inventories, warranties and metals with names that sound like a crossword fight. Diluted EPS was $1.74 on 229.8M diluted shares, which is the clean headline. The less glossy part is just as important: $1.14B of net inventory and $3.8M of warranty accrual increases for warranties issued. The market likes a tidy earnings line; the filings bring the screws, gauges and aftercare bill, because industrial earnings do not arrive by vapour. They arrive in parts...
Run the full workstation report for the complete source rail, saved history, export controls, and the full Market Wit file for AME.
What changed for AMETEK INC/ today
AMETEK's strongest current development is the 2026-05-26 8-K on SEC EDGAR: the company said it had completed its acquisition of First Aviation Services, described in the filed press release as a provider of highly engineered defence and aviation maintenance, repair and overhaul services and a manufacturer of related proprietary products. That gives the daily file a concrete operating hook. The story is not just AME as a symbol; it is an equity tied to products, repair work, aviation service demand and the discipline of integrating a named acquired business.
The company evidence points to an industrial manufacturer and contractor whose products can carry real supply-chain consequences. The 2026-05-19 Form SD says AMETEK evaluated its current product lines and determined that certain products it manufactures or contracts to manufacture contain tin, tungsten, tantalum and/or gold, known as 3TG. That does not prove a disruption or a fresh controversy. It proves the business has a materials trail serious enough to require a conflict minerals report, with the company directing readers to its investor governance site for that report.
The latest parsed SEC financial rail is substantial. For the 10-Q period ended 2026-03-31, AMETEK reported revenue from contracts with customers, excluding assessed tax, of $1.93B, operating income of $514.9M, net income attributable to parent of $399.4M and diluted EPS of $1.74 on 229.8M diluted shares. The same period shows assets of $16.31B, liabilities of $5.39B, stockholders' equity attributable to parent of $10.92B, cash and cash equivalents of $481.2M, net cash provided by operating activities of $451.5M and payments to acquire property, plant and equipment of $25.5M. The latest supplied annual R&D figure is $236.1M for the 10-K period ended 2025-12-31.
The supplied rail includes SEC filing URLs, the SEC company filing index, SEC submissions JSON and SEC companyfacts JSON. It does not include a chart route, price level, volume read, valuation multiple, analyst note or TradingView context, so this report cannot make a claim about candles, support, resistance or market timing. The market mechanism that can be described from the evidence is simpler: AME is an equity whose current file is being shaped by filed operating results, cash generation, balance sheet scale, a defence and aviation MRO acquisition, and a minerals disclosure attached to product manufacturing.
The risk in the file is not that the evidence is empty; it is that it is deliberately narrow. The First Aviation filing proves completion and business description, but not deal price, expected contribution, integration cost or future margin. The Form SD proves 3TG exposure in certain products, but not the weight, supplier concentration or financial cost of compliance. The companyfacts numbers prove the latest parsed financial base, yet they do not supply guidance, segment pressure, dividend action or buyback detail. The next deeper file would need those missing issuer facts before the story could move from documented condition to measured expectation.
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
Atlas has no approved static OHLC cache attached for AME yet, so the profile renders the verified TradingView chart route directly and keeps the full-chart link as fallback.
Run an Atlas research workflow on AME
FreedomCore Atlas operates research workstation templates for company snapshots, DCF, LBO, KYC, NAV tie-outs, and council-grade equity briefs. Each workflow uses public-source filings and structured prompts.
Open Atlas workstation ->Save AME research and exports
Free Atlas users can run full browser research reports from the workstation. Atlas Pro adds 25 custom runs a day, saved research history, email delivery, PDF/CSV exports, and a 25-symbol watchlist. £12/mo founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
AME FAQ
What is AMETEK INC/ (AME)?AMETEK INC/ is an industrial instruments for measurement, display, and control issuer listed as AME on NYSE. This free Atlas page links SEC CIK 1037868, Nasdaq Trader...
AMETEK INC/ is an industrial instruments for measurement, display, and control issuer listed as AME on NYSE. This free Atlas page links SEC CIK 1037868, Nasdaq Trader and TradingView NYSE:AME, related symbols and the workstation route before a full report is run.
What does Atlas show for AME?The AME page gives the free Atlas profile for AMETEK INC/: listing identity, chart route, related symbols, source authority and the workstation route. The chart route...
The AME page gives the free Atlas profile for AMETEK INC/: listing identity, chart route, related symbols, source authority and the workstation route. The chart route is NYSE:AME; the stable page route is /stocks/AME/. Visible source links include SEC EDGAR CIK 1037868, Nasdaq Trader and TradingView NYSE:AME. Atlas files AME under USA Stocks for browsing.
How often is the AME page updated?The /stocks/AME/ URL is stable. Atlas updates the free AME page when the symbol-universe record, listing identity, source links, chart route, related-symbol links or...
The /stocks/AME/ URL is stable. Atlas updates the free AME page when the symbol-universe record, listing identity, source links, chart route, related-symbol links or published public answer changes.
Which sources does Atlas use for AME?For AME, Atlas starts with SEC EDGAR CIK 1037868, Nasdaq Trader and TradingView NYSE:AME. The SEC CIK 1037868 route is the issuer filing anchor. Nasdaq Trader confirms...
For AME, Atlas starts with SEC EDGAR CIK 1037868, Nasdaq Trader and TradingView NYSE:AME. The SEC CIK 1037868 route is the issuer filing anchor. Nasdaq Trader confirms the listed-symbol identity used by the public directory. NYSE:AME is the chart route shown on the free page. Full workstation reports may add fresh filings, issuer documents, holdings, news, macro context or model-reviewed notes when available.
Can Atlas run a full research brief on AME?Yes. The workstation can open AME, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open AME, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this AME page investment advice?No. The AME page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a buy or sell instruction, or a...
No. The AME page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a buy or sell instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-06-19. Browse FreedomCore Atlas research notes →